| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/29/2008 | CA2326283C Brassica napus with early maturity (early napus) and resistance to an ahas-inhibitor herbicide |
| 04/29/2008 | CA2315546C Constitutive maize promoters |
| 04/29/2008 | CA2230372C Quantitation of p97 to diagnose and monitor alzheimer's disease |
| 04/29/2008 | CA2213533C Resorbable extracellular matrix for reconstruction of cartilage tissue |
| 04/29/2008 | CA2120353C Cell cycle controlling compositions and methods of using same |
| 04/29/2008 | CA2113374C Improvements in somatic embryogenesis |
| 04/24/2008 | WO2008048931A1 Methods and compositions for differential expansion of fetal cells in maternal blood and their use |
| 04/24/2008 | WO2008048924A2 Biomarkers of multiple sclerosis |
| 04/24/2008 | WO2008048671A1 Embryonic-like stem cells derived from adult human peripheral blood and methods of use |
| 04/24/2008 | WO2008048647A1 Modulation of the phosphatidylinositol-3-kinase pathway in the differentiation of human embryonic stem cells |
| 04/24/2008 | WO2008048229A2 Stabilized lyophilized blood platelets |
| 04/24/2008 | WO2008047950A1 Environmental stress-responding promoter, and tissue-specific gene expression method using the same |
| 04/24/2008 | WO2008047802A1 D-serine dehydratase and use thereof |
| 04/24/2008 | WO2008047480A1 Method for control of distribution of mutation sites in variable region of antibody gene |
| 04/24/2008 | WO2008046993A2 New marine-originating biological product, method for producing the same and uses threof |
| 04/24/2008 | WO2008046855A1 Glucanotransferase |
| 04/24/2008 | WO2008027848A3 Transcription factors for differentiation of adult human olfactory progenitor cells |
| 04/24/2008 | WO2008026928A3 Repair of cartilage tissue using a matrix gel containing chondrocytes |
| 04/24/2008 | WO2008026226A3 Self-renewing master adult pluripotent stem cells |
| 04/24/2008 | WO2008025992A3 Methods of expanding non-effector cd8 t-cell populations |
| 04/24/2008 | WO2008024372A3 Pullulanase variants with increased productivity |
| 04/24/2008 | WO2008012675A3 Method for the production of multipotent stem cells, relative kits and uses in the medical field |
| 04/24/2008 | WO2008012534A3 Retinoids and small molecules as nrf2 antagonists for use in the treatment of diseases associated with abnormal cell proliferation |
| 04/24/2008 | WO2007146334A3 Co-culture lymphoid tissue equivalent (lte) for an artificial immune system (ais) |
| 04/24/2008 | WO2007146123A3 Placental niche and use thereof to culture stem cells |
| 04/24/2008 | WO2007141657A3 Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation |
| 04/24/2008 | WO2007127787A3 Insulin autoantigen-specific regulatory cd4+ t cells |
| 04/24/2008 | WO2007110785A3 Methods and materials for the generation of regulatory t cells |
| 04/24/2008 | WO2007109677A3 A novel method of protecting islet cells from apoptosis during the donor harvesting process |
| 04/24/2008 | WO2007076493A3 Methods and reagents for genotyping hcv |
| 04/24/2008 | US20080098496 Producing homozygous non-human organism from a heterozygous non-human organism via second division restitution; meiosis and tissue regeneration |
| 04/24/2008 | US20080098493 Carrots having increased lycopene content |
| 04/24/2008 | US20080098490 Recombinant animal for use as bioreactor in production of human immunoglobulins |
| 04/24/2008 | US20080097607 Pigmentable epidermis equivalent prepared from matrix cells and methods for the production thereof |
| 04/24/2008 | US20080097082 Nucleotide sequences coding recombinant protein for use in prevention and treatment of hyperphosphatemia |
| 04/24/2008 | US20080096981 modulating activities associated with the IL-9 pathway for the treatment of atopic allergies like asthma; autoimmune diseases; new genes tightly expressed in association with an inflammatory response in the airways mediated by type 2 helper T-cells (TH). These genes have been designated TH2AF1 |
| 04/24/2008 | US20080096980 which cause various pathologies including Parkinson's, Huntington's, and Alzheimer's Diseases; agent that induces a survival response by the cell; induces sequestration of toxic protein in an inclusion body; |
| 04/24/2008 | US20080096975 A copolymer of an N-alkyl acrylamide, preferably N-isopropyl acrylamide, (meth)acrylic acid, and an amine-reactive group and having a polyester macromer in the backbone; cell growth substrates, wound healing drug delivery; fluid below room temperature, gelation at physiological temperature; nontoxic |
| 04/24/2008 | US20080096892 C-Kit Modulators And Methods Of Use |
| 04/24/2008 | US20080096834 Administering a nucleic acid encoding a trout E-domain peptide or somatomedin as antiproliferative, anticarcinogenic and/or antitumor agent in mammals or fish |
| 04/24/2008 | US20080096833 Diagnostic drugs and kits; coded for human proto-oncogene Pim-3, an antibody specific thereto; short interence RNA; genetic engineering |
| 04/24/2008 | US20080096824 administering oligopeptides to prevent apoptosis in stroke, heart attack or ischemia patients and patients having degenerative diseases, infection caused by bacteria, viruses or protozoa, and reduce side effects of chemotherapy and radiotherapy |
| 04/24/2008 | US20080096821 Cytostatin II |
| 04/24/2008 | US20080096820 Prodomain modulators of ADAM 10 |
| 04/24/2008 | US20080096819 Amino acid substituted molecules |
| 04/24/2008 | US20080096813 Generation of potent dominant negative transcriptional inhibitors |
| 04/24/2008 | US20080096806 Compositions and methods for inhibiting microbial adhesion |
| 04/24/2008 | US20080096279 Expression vector comprising reporter enzyme for enhanced expression in microorganism; improving heterologouus gene expression in host cells |
| 04/24/2008 | US20080096277 Expession vector comprising nucleotide sequences which code and enhance prolamin polypeptide transcription and RNA interfereing sequence which decrease expression of preferential storage proteins in seeds |
| 04/24/2008 | US20080096276 Expression vector comprising nucleotide sequences coding undecaprenyl diphosphate and dehydrodolichyl diphosphate synthases for use as tool in enhancing plant defenses |
| 04/24/2008 | US20080096275 Protein For Improving Cell-Attachment Efficiency and Use Thereof |
| 04/24/2008 | US20080096274 Recombinant alphavirus vectors and methods of using same |
| 04/24/2008 | US20080096273 Using nutrient broth comprising embryonic stem cells to propagate nervous system cells |
| 04/24/2008 | US20080096272 Apparatus for propagating preferential tissues; bioreactors |
| 04/24/2008 | US20080096270 Plate and method for high throughput screening |
| 04/24/2008 | US20080096269 Multiple well plate for holding a porous frit that supports a tissue which is to be bathed in a media that is regularly aspirated and refreshed by a top-loading multi-head pipette device; tissue culture and engineering |
| 04/24/2008 | US20080096253 Methods of making nanotechnological and macromolecular biomimetic structures |
| 04/24/2008 | US20080096250 Expression vector comprising nucleotide sequences coding inflammatory response polypeptide for use in treatment and prevention of inflammation |
| 04/24/2008 | US20080096249 Agarase and gene thereof |
| 04/24/2008 | US20080096228 Using lymphocyte enhancer factor-1 (LEF-1) expression as evaluative tool in diagnosing cell proliferative disorders |
| 04/24/2008 | US20080096227 Identifying agonist/antagonist of calcium release activated Ca+2 (CRAC) channel via variation in membrane premeability |
| 04/24/2008 | US20080096224 Fusion proteins comprising pleckstrin homology domain of Akt (protein kinase B) and a pseudoligand containing acidic amino acid residues, sandwiched between resonance energy transfer (RET) pairs, such as cyan and yellow mutants of green fluorescent protein; high throughput assay; drug screening |
| 04/24/2008 | US20080096222 Compositions And Methods Based Upon The Kinase Haspin |
| 04/24/2008 | US20080096202 Transgenic mammal comprising pancreatic ER kinase gene (PERK) for identifying modulators for prevention and treatment of nervous system disorders |
| 04/24/2008 | US20080096187 Molecular Scaffolds for HIV-1 Epitopes |
| 04/24/2008 | US20080095889 Nucleotide sequences coding enzymatic polypeptide for use in the preparation of bread doughs |
| 04/24/2008 | US20080095833 Immunogens; expression cassettes; gag genes; tat proteins; DNA vaccines; vpr genes; rev genes; envelope genes; antigen presenting cells; liposomes |
| 04/24/2008 | US20080095819 Antiproliferative agents; connexins; reducing density of astrocytes; increasing density of neurons; hair growth; cosmetic surgery |
| 04/24/2008 | US20080095793 Expression vector comprising nucleotide sequences coding protein fusion for use in treatment and prevention of microorganismal infection |
| 04/24/2008 | US20080095792 Polypeptides For Inducing A Protective Immune Response Against Staphylococcus Aureus |
| 04/24/2008 | US20080095787 Adjuvants and methods of use |
| 04/24/2008 | US20080095781 Agonist antibody specific for death receptor-4 (DR4)polypeptide for use in treatment and prevention of infection, nervous system, cell proliferative and autoimmune disorders |
| 04/24/2008 | US20080095780 Binding Molecules For Treatment And Detection Of Cancer |
| 04/24/2008 | US20080095779 Using modulators which alter protein DNA binding as tool in prevention and treatment of cell proliferative disorders |
| 04/24/2008 | US20080095775 Immunoglobulin for use in prevention and treatment of diabetes, arthritis, autoimmune, skin, respiratory and inflammatory disorders; immunotherapy |
| 04/24/2008 | US20080095773 Polypeptides homologous to vegf and bmp1 |
| 04/24/2008 | US20080095763 Using cyclin dependent kinase -9 (CDK9) as diagnostic tool in identifying modulators of insulin like growth factor function; antitumor agents; antihypoxic agents |
| 04/24/2008 | US20080095762 Glycoprotein compositions |
| 04/24/2008 | US20080095751 Atherosclerosis |
| 04/24/2008 | US20080095750 Use of adipose-derived stem cells for treatment of leukodystrophies |
| 04/24/2008 | US20080095749 Mesenchymal stem cells and uses therefor |
| 04/24/2008 | US20080095746 Using cells expressing podocalyxin-like protein 1 (PCLP1) as source for propagating progenitor cells for use in treatment of blood and vascular diseases; regenerative medicine |
| 04/24/2008 | US20080095743 Using immunoglobulins to identify and isolate skeletal-based precursor of cardiomyocytes (Spoc) for use in treatment of nervous system disorders |
| 04/24/2008 | US20080095709 Method and apparatus for installation of dental implant |
| 04/24/2008 | US20080095700 DR4 antibodies and uses thereof |
| 04/24/2008 | US20080095662 Method for decellularizing foreign material to produce bioprostheses |
| 04/24/2008 | CA2667067A1 Antibody antagonists of interleukin-13 receptor .alpha.1 |
| 04/24/2008 | CA2666789A1 Embryonic-like stem cells derived from adult human peripheral blood and methods of use |
| 04/23/2008 | EP1914319A2 Polymorphisms and new genes in the region of the human hemochromatosis gene |
| 04/23/2008 | EP1914312A2 Virulence genes and proteins, and their use |
| 04/23/2008 | EP1914310A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/23/2008 | EP1914301A1 Anti-CD80 antibodies |
| 04/23/2008 | EP1914300A1 Tooth regeneration method |
| 04/23/2008 | EP1914243A2 Anti-CD40 monoclonal antibody |
| 04/23/2008 | EP1913813A1 Transgenic Mouse for screening and for studies of the pharmacodynamics and pharmacokinetics of ligands acting on intracellular receptors, and method for the preparation thereof |
| 04/23/2008 | EP1913387A1 Method for identifying regulatory t cells |
| 04/23/2008 | EP1913132A1 Cloned canines and method for producing thereof |
| 04/23/2008 | EP1913131A2 Method for isolating stem cells and stem cells derived from a pad-like tissue |
| 04/23/2008 | EP1913130A2 Cell/ligand marking system, wherein the marker is of eph type, cell material comprising said system, method for preparing same and proangiogenetic use |
| 04/23/2008 | EP1913129A1 Cardiomyocyte cell populations |